Systematic metabolic engineering of Escherichia coli for high-level production of pseudouridine via pathway optimization and precursor enhancement
Synthetic and Systems Biotechnology · 2026-12 · 14 · 32-40
DOI: 10.1016/j.synbio.2026.03.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthetic and Systems Biotechnology, 2026-12. Verfasst von Jing Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, C…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Discipline Innovation Project, Jiangnan University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Pseudouridine, the C5-ribose epimer of uridine with significant biological functions and clinical applications, was efficiently produced through systematic metabolic strategy of Escherichia coli in this study. Initial overexpression of pseudouridine-5-phosphate glycosylase gene psuG and alkaline phosphatase gene YjjG in E. coli pRSFDuet-1-YjjG-psuG yielded 0.43 g L-1 pseudouridine, which increased 8.56-fold with 5 g L-1 uridine supplementation. Subsequent deletion of thrA, psuT, argF, and pepA enhanced titer by 1.29-fold in E. coli ΔthrAΔpsuTΔargFΔpepA pRSFDuet-1-YjjG-psuG, while ribonucleoside hydrolase gene rihA overexpression boosted titer to 5.57 g L-1. Further optimization through deleting the uridine kinase gene udk and overexpressing the ribokinase gene rbsK in strain E. coli ΔthrAΔpsuTΔargFΔpepAΔudkΔudpΔppnp pRSFDuet-1-YjjG-psuG pCDFDuet-1-rihA-rbsK achieved 6.23 g L-1 pseudouridine, increasing to 11.34 g L-1 with two-stage uridine feeding. Fed-batch fermentation in a 5-L bioreactor yielded a record 102.2 g L-1 pseudouridine. This work provides an efficient and scalable bioprocess for industrial pseudouridine manufacturing to meet the growing demands of mRNA-based applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biotechnology and Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, China.
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
Förderung
- Higher Education Discipline Innovation Project
- Jiangnan University
- National Key Research and Development Program of China
Zitieren
APA
Song, J., Shen, W., Xia, Y., Zhou, L., Zhou, Y., Yang, H., & Chen, X. (2026). Systematic metabolic engineering of Escherichia coli for high-level production of pseudouridine via pathway optimization and precursor enhancement. Synthetic and Systems Biotechnology, 14, 32-40. https://doi.org/10.1016/j.synbio.2026.03.013
Vancouver
Song J, Shen W, Xia Y, Zhou L, Zhou Y, Yang H, et al. Systematic metabolic engineering of Escherichia coli for high-level production of pseudouridine via pathway optimization and precursor enhancement. Synthetic and Systems Biotechnology. 2026;14:32-40. doi:10.1016/j.synbio.2026.03.013
BibTeX
@article{Song2026,
author = {Song, Jing and Shen, Wei and Xia, Yuanyuan and Zhou, Li and Zhou, Yingjun and Yang, Haiquan and Chen, Xianzhong},
title = {Systematic metabolic engineering of Escherichia coli for high-level production of pseudouridine via pathway optimization and precursor enhancement},
journal = {Synthetic and Systems Biotechnology},
year = {2026},
volume = {14},
pages = {32--40},
doi = {10.1016/j.synbio.2026.03.013}
}
EUVIMED